Latest Regulatory Progress News

Deterra Royalties has agreed to sell its non-core gold offtakes and royalties to Vox Royalty Corp for US$60 million, marking the completion of its divestment of Trident-acquired assets and reinforcing its strategic focus on base and battery metals.

The European Medicines Agency has approved continuous bi-monthly dosing of CLINUVEL’s SCENESSE® for adult erythropoietic protoporphyria patients, removing previous annual dose limits and aligning Europe with US treatment standards.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.

Ballard Mining reports strong infill drilling results at its Baldock gold deposit, confirming and refining a high-grade resource and targeting a maiden reserve by mid-2026. The ongoing program highlights potential resource growth beyond current estimates.

Echo IQ has completed its presentation to the CPT Editorial Panel for a Category III CPT code for EchoSolv AS, with a decision expected from the American Medical Association in the coming weeks. Meanwhile, the company is advancing US deployments and FDA clearance efforts.

American Uranium Limited is set to commence hydrogeologic testing and resource expansion drilling at its Lo Herma uranium project in Wyoming during the fourth quarter of 2025, aiming to boost its mineral resource base and support upcoming scoping studies.

OncoSil Medical’s PANCOSIL Phase 1-2 study reveals promising safety and feasibility for a novel CT-guided pancreatic cancer therapy, with survival outcomes exceeding historical benchmarks.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Renergen Limited and ASP Isotopes Inc. have proactively extended the deadline to fulfill outstanding conditions for their Scheme of Arrangement offer to 28 November 2025, following key regulatory approvals and ongoing collaboration.

EVE Health Group has appointed Dr Fiona Cousins as the inaugural member of its Scientific Advisory Board, reinforcing its commitment to advancing treatments for dysmenorrhoea and endometriosis ahead of the commercial launch of Dyspro™.

St Barbara Limited has withdrawn its Supreme Court appeal over reclamation conditions at the Touquoy Mine, citing improved regulatory cooperation in Nova Scotia, and is now investigating reopening the mine to process 3.1 million tonnes of low and medium grade gold stockpiles.

New Frontier Minerals has appointed GeoDrill Australia to lead its inaugural drilling campaign at the Harts Range Project, targeting a suite of critical minerals vital to modern technologies and energy transition.